146 related articles for article (PubMed ID: 25628223)
21. Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3.
Brink HJ; van Senten JR; De Vries-van Leeuwen IJ; da Costa Pereira D; Piersma SR; Jimenez CR; Centorrino F; Ottmann C; Siderius M; Smit MJ; de Boer AH
ACS Chem Biol; 2022 Nov; 17(11):2972-2978. PubMed ID: 36255265
[TBL] [Abstract][Full Text] [Related]
22. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
23. CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.
Chao TT; Maa HC; Wang CY; Pei D; Liang YJ; Yang YF; Chou SJ; Chen YL
APMIS; 2016 Dec; 124(12):1031-1037. PubMed ID: 27649840
[TBL] [Abstract][Full Text] [Related]
24. CIP2A is associated with human breast cancer aggressivity.
Côme C; Laine A; Chanrion M; Edgren H; Mattila E; Liu X; Jonkers J; Ivaska J; Isola J; Darbon JM; Kallioniemi O; Thézenas S; Westermarck J
Clin Cancer Res; 2009 Aug; 15(16):5092-100. PubMed ID: 19671842
[TBL] [Abstract][Full Text] [Related]
25. From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.
Chen B; Hu H; Chen X
Front Genet; 2023; 14():1110656. PubMed ID: 36911405
[TBL] [Abstract][Full Text] [Related]
26. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
[TBL] [Abstract][Full Text] [Related]
27. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
[TBL] [Abstract][Full Text] [Related]
28. Relationship between CIP2A expression, and prognosis and MDR-related proteins in patients with advanced gastric cancer.
Chen JS; Wu BB; Bao HL; Du JM; Zhang SC; Zheng YH
Int J Clin Exp Pathol; 2015; 8(11):15007-12. PubMed ID: 26823836
[TBL] [Abstract][Full Text] [Related]
29. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
30. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
Chen KF; Yen CC; Lin JK; Chen WS; Yang SH; Jiang JK; Lan YT; Lin CC; Yu HC; Hsu HM; Lin WL; Teng HW
BMC Cancer; 2015 Apr; 15():301. PubMed ID: 25896895
[TBL] [Abstract][Full Text] [Related]
31. CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells.
Lin YC; Chen KC; Chen CC; Cheng AL; Chen KF
Oral Oncol; 2012 Jul; 48(7):585-93. PubMed ID: 22342571
[TBL] [Abstract][Full Text] [Related]
32. CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression.
Wu Y; Gu TT; Zheng PS
Cancer Lett; 2015 Jan; 356(2 Pt B):646-55. PubMed ID: 25458953
[TBL] [Abstract][Full Text] [Related]
33. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
[TBL] [Abstract][Full Text] [Related]
34. Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.
Shi F; Ding Y; Ju S; Wu X; Cao S
Biomarkers; 2014 Feb; 19(1):70-6. PubMed ID: 24369732
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
Xu P; Huang Q; Xie F; Xu XL; Shao F
Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of sCIP2A levels in breast cancer.
Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
[TBL] [Abstract][Full Text] [Related]
37. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
38. Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.
Routila J; Bilgen T; Saramäki O; Grénman R; Visakorpi T; Westermarck J; Ventelä S
J Oral Pathol Med; 2016 May; 45(5):329-37. PubMed ID: 26436875
[TBL] [Abstract][Full Text] [Related]
39. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells.
Li W; Ge Z; Liu C; Liu Z; Björkholm M; Jia J; Xu D
Clin Cancer Res; 2008 Jun; 14(12):3722-8. PubMed ID: 18559589
[TBL] [Abstract][Full Text] [Related]
40. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
